Back to results
US 8,299,019 B2Granted
Uses of modified ELR-CXC chemokine G31P to treat cancer
OwnerJohn R. Gordon, Fang Liinventors
Life of this patent
Estimating the term…
Abstract
Described herein is the use of a modified human chemokine, GS-CXCL8(3-72)K11R/G31P or G31P in the treatment of a number of cancers, including but by no means limited to prostate cancer, liver cancer and melanoma.
Claims9
A method of treating a cancer selected from the group consisting of melanoma, prostate cancer, pancreatic cancer and hepatic cancer in an individual in need of such treatment comprising administering to said individual an effective amount of G31P (SEQ ID NO:1).
Dependencies are inferred from the claim text.